Navigation Menu

Clinical Trial External Search


Children (age < 18 years)
Adults (age >= 18 years)

Researcher Profile

Researcher Display

Roderick Clark, MD, MSc

Roderick Clark, MD, MSc

Assistant Professor, Department of Urology
Assistant Professor, Department of Public Health Sciences
Scientific Program:Cancer Control
RKC5628@psu.edu

Research Interests

Dr. Roderick Clark has published numerous peer-reviewed manuscripts related to the epidemiology, genetics and clinical management of Urologic cancers. He has a research interest in prostate cancer and how we can better identify and treat individuals who are at high-risk of dying from this disease. His research also focuses on changing population-level trends in Urologic cancers using large administrative databases.

  • Therapeutics
  • Prostatic Neoplasms
  • Survival
  • Population
  • Neoplasms
  • Mortality
  • Testicular Neoplasms
  • Neurogenic Urinary Bladder
  • Genetic Testing
  • Ontario
  • Urology
  • Observational Studies

Recent Publications

2023

Clark, R & Raman, JD 2023, 'Re: Less is more: single dose versus extended antibiotic prophylaxis for transperineal prostate biopsy', Canadian Journal of Urology, vol. 30, no. 4, pp. 11605-11606.
Aminoltejari, K, Hird, AE, Klaassen, Z, Satkunasivam, R, Kulkarni, GS, Luckenbaugh, AN, Laviana, AA, Wallis, CJD & Clark, R 2023, 'Robotic Versus Open Cystectomy for Bladder Cancer: Synthesizing the Data from Current Systematic Reviews and Meta-Analyses', Annals of Surgical Oncology, vol. 30, no. 5, pp. 2976-2987. https://doi.org/10.1245/s10434-022-12692-w
McAlpine, K, Clark, R, Spiess, PE, Necchi, A, Gage, K & Hamilton, RJ 2023, 'The Importance of Repeat Imaging Prior to Treatment Decision-making in Testicular Cancer: Commentary From the Inaugural Global Society of Rare Genitourinary Tumors Summit', Clinical Genitourinary Cancer, vol. 21, no. 3, pp. 418.e1-418.e6. https://doi.org/10.1016/j.clgc.2022.12.005

2022

Finch, A, Clark, R, Vesprini, D, Lorentz, J, Kim, RH, Thain, E, Fleshner, N, Akbari, MR, Cybulski, C & Narod, SA 2022, 'An appraisal of genetic testing for prostate cancer susceptibility', npj Precision Oncology, vol. 6, no. 1, 43. https://doi.org/10.1038/s41698-022-00282-8
McAlpine, K, Clark, R, Jiang, M, Hansen, A, Hemminki, O & Hamilton, RJ 2022, 'Case - Intra-abdominal metastases following ventriculoperitoneal shunt insertion for primary intracranial germ cell tumor', Journal of the Canadian Urological Association, vol. 16, no. 9. https://doi.org/10.5489/cuaj.7895
Clark, R, Herrera-Caceres, J, Kenk, M & Fleshner, N 2022, 'Clinical Management of Prostate Cancer in High-Risk Genetic Mutation Carriers', Cancers, vol. 14, no. 4, 1004. https://doi.org/10.3390/cancers14041004
Clark, R & Klotz, L 2022, 'Focal therapy: Definition and rationale', Current Opinion in Urology, vol. 32, no. 3, pp. 218-223. https://doi.org/10.1097/MOU.0000000000000975
Padayachee, J, Clark, R, Warde, P & Hamilton, RJ 2022, 'Management of stage I testicular cancer', Current Opinion in Urology, vol. 32, no. 1, pp. 17-23. https://doi.org/10.1097/MOU.0000000000000942
Jayalath, VH, Clark, R, Lajkosz, K, Fazelzad, R, Fleshner, NE, Klotz, LH & Hamilton, RJ 2022, 'Statin Use and Survival among Men Receiving Androgen-Ablative Therapies for Advanced Prostate Cancer: A Systematic Review and Meta-analysis', JAMA network open, vol. 5, no. 11, pp. E2242676. https://doi.org/10.1001/jamanetworkopen.2022.42676
Clark, R, Vesprini, D & Narod, SA 2022, 'The Effect of Age on Prostate Cancer Survival', Cancers, vol. 14, no. 17, 4149. https://doi.org/10.3390/cancers14174149
Tiwari, R, Clark, R & Fleshner, N 2022, 'The role of prophylactic prostatectomy as a primary prevention strategy in high-risk germline mutation carriers', Current Opinion in Urology, vol. 32, no. 5, pp. 445-450. https://doi.org/10.1097/MOU.0000000000001019
Clark, R 2022, “Prostate Cancer: A Matter of Facts”: Prostate Cancer Segment. ABC27 News, Harrisburg, PA, USA.

2021

Clark, R, McAlpine, K & Fleshner, N 2021, 'A Clinical Trial of Prophylactic Prostatectomy for BRCA2 Mutation Carriers: Is Now the Time?', European Urology Focus, vol. 7, no. 3, pp. 506-507. https://doi.org/10.1016/j.euf.2021.04.018
Clark, R, Kenk, M, McAlpine, K, Thain, E, Farncombe, KM, Pritchard, CC, Nussbaum, R, Wyatt, AW, de Bono, J, Vesprini, D, Bombard, Y, Lorentz, J, Narod, S, Kim, R & Fleshner, N 2021, 'The evolving role of germline genetic testing and management in prostate cancer: Report from the princess margaret cancer centre international retreat', Journal of the Canadian Urological Association, vol. 15, no. 12. https://doi.org/10.5489/CUAJ.7383

2020

Wang, Y, Hoogenes, J, Clark, R, Wong, NC, Blankstein, U, Randhawa, H, Lovatt, C, Kim, K, Stern, N, Law, J, Sami, S, Uy, M, Moore, C, Shayegan, B, Kapoor, A, Lambe, S, Davies, T, Dave, S, Sener, A & Matsumoto, ED 2020, 'Development, implementation, and evaluation of a competency-based didactic and simulation-focused boot camp for incoming urology residents: Report of the first three years', Journal of the Canadian Urological Association, vol. 15, no. 4. https://doi.org/10.5489/CUAJ.6679
Lavi, A, Clark, R, Ly, TL, Nair, SM, Hetou, K, Haan, M & Power, NE 2020, 'Long-term Testis Cancer Survivors in Canada—Mortality Risks in a Large Population-based Cohort', European Urology Open Science, vol. 22, pp. 54-60. https://doi.org/10.1016/j.euros.2020.10.005